Completing data — refresh the page later to see the latest
84-34-4COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)[C@@H]1OCSZLZWPPUNLXJEA-QEGASFHISA-NRescinnamine is an odorless white to cream colored crystalline powder. (NTP, 1992)
84-34-4CHEMBL1668CHEBI:28572Fine needles from benzene
WHITE, OR PALE BUFF TO CREAM-COLORED CRYSTALLINE POWDER
less than 1 mg/mL at 61 °F (NTP, 1992)
Practically insol in water; moderately sol in methanol, benzene, chloroform, and other organic solvents
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
460 to 462 °F (in vacuum) (NTP, 1992)
238-239 °C (vacuum)
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).
C - Cardiovascular system
QC - Cardiovascular system
Used to treat hypertension. Rescinnamine inhibits angiotensin-converting enzyme. ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. Angiotensin II also stimulates aldosterone secretion by the adrenal cortex and general vasoconstriction, both of which lead to increases vascular resistance. By inhibiting angiotensin II, aldosterone reabsorption is decreased as well as vasoconstriction. This combined effect serves to decrease blood pressure.
Rescinnamine Binds to and inhibits the angiotensin converting enzyme. Rescinnamine competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in decreased plasma angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blood pressure and stimulation of baroreceptor reflex mechanisms, which leads to decreased vasopressor activity and to decreased aldosterone secretion.
SEE RAUWOLFIA ALKALOIDS. ...PRODUCE VARIABLE LOWERING OF MEAN ARTERIAL BLOOD PRESSURE...BY BLOCKING AFFERENT IMPULSES WHICH...STIMULATE SYMPATHETIC VASOPRESSOR REFLEXES NEAR LEVEL OF HYPOTHALAMUS &/OR BY DECR REACTIVITY OF PERIPHERAL SYMPATHETIC...SYSTEM THROUGH DEPLETION OF NOREPINEPHRINE @ NERVE ENDINGS. /RAUWOLFIA.../
SEE RAUWOLFIA ALKALOIDS. ALSO EXHIBIT A NON-HYPNOTIC SEDATIVE EFFECT WHICH MAY BE ASSOCIATED WITH THEIR ABILITY TO MODIFY CONCN OF SEROTONIN &/OR NOREPINEPHRINE IN BRAIN STEM. /RAUWOLFIA ALKALOIDS/
RAUWOLFIA ALKALOIDS ARE ABSORBED READILY FROM GI TRACT & FROM PARENTERAL SITES OF INJECTION.
SEE RAUWOLFIA ALKALOIDS. ...PASS PLACENTAL BARRIER & MAY AFFECT NEWBORN. /RAUWOLFIA ALKALOIDS/
EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.
SMALL SPILLS AND LEAKAGE: If a spill of this chemical occurs, FIRST REMOVE ALL SOURCES OF IGNITION, then you should dampen the solid spill material with acetone and transfer the dampened material to a suitable container. Use absorbent paper dampened with acetone to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Solvent wash all contaminated surfaces with acetone followed by washing with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.
SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.
RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)
SEE RAUWOLFIA ALKALOIDS. OVERDOSAGE...CHARACTERIZED BY CENTRAL DEPRESSION...PTOSIS, MIOSIS, & CATATONIA IN SEVERE CASES. /RAUWOLFIA ALKALOIDS/
...USEFUL FOR MANAGEMENT OF MILD, LABILE HYPERTENSION & AS TRANQUILIZING AGENT IN AGITATED PT WITH SIMPLE NEUROSES & FRANK PSYCHOSES.
...ADMIN ORALLY...HAVE CUMULATIVE ACTION; MAX RESPONSE USUALLY NOT OBSERVED UNTIL SEVERAL DAYS TO 2 WK AFTER THERAPY IS INITIATED, & SOME EFFECT MAY PERSIST UP TO 4 WK AFTER THERAPY IS DISCONTINUED. /RAUWOLFIA ALKALOIDS/
TREATMENT: 3. EPIGASTRIC PAIN &...PEPTIC ULCER MAY REQUIRE LOCAL ANTACID THERAPY... 4. ...MOTOR DYSFUNCTION...OFTEN CONTROLLED BY DRUGS USEFUL...IN PARKINSONISM, BUT SAFER COURSE IS TO DISCONTINUE RESERPINE THERAPY... /RESERPINE/
TREATMENT: 5. IN ACUTELY POISONED PT...NOT IN COMA, EMESIS...OR GASTRIC LAVAGE...EVEN SEVERAL HR AFTER INGESTION... LEAVE SALINE CATHARTIC IN STOMACH. 6. ...COMA WITH HYPOTENSION...RESPONDS TO CONSERVATIVE SUPPORTIVE THERAPY. ANALEPTIC DRUGS...PROBABLY MORE DANGEROUS THAN BENEFICIAL... /RESERPINE/
TREATMENT: 7. USE BLANKETS &...EXTERNAL...HEAT TO MAINTAIN BODY TEMP... 8. UNLESS BLOOD PRESSURE BECOMES VERY LOW, AVOID VASOPRESSOR DRUGS... MAY LEAD TO EXAGGERATED CARDIOVASCULAR RESPONSE... 9. BECAUSE OF UNCERTAIN CARDIAC STATUS...AVOID RAPID IV INFUSIONS... /RESERPINE/
TREATMENT: 10. ALTHOUGH NOT DESCRIBED IN CLINICAL POISONINGS, RAPID DIGITALIZATION WITH OUABAIN OR ACETYLSTROPHANTHIDIN MAY AID...ADEQUATE CIRCULATION, ALTHOUGH THERE MAY BE HIGH RISK OF CARDIAC ARRHYTHMIAS. /RESERPINE/
SEE RAUWOLFIA ALKALOIDS. A SYMPATHOMIMETIC...SUCH AS METHAMPHETAMINE IS SUGGESTED TREATMENT FOR OVERDOSAGE. /RAUWOLFIA ALKALOIDS/
Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).
Therap cat: Antihypertensive
MEDICATION
A PURIFIED ESTER ALKALOID OF THE ALSEROXYLON FRACTION OF RAUWOLFIA SPECIES.
Found in Rauwolfia serpentina Benth., Apocynaceae: Haack et al., Naturwiss. 41, 214 (1954); Ordway, Guercio, US pat 2,876,228 (1959 to Pfizer); Klohs et al, US pat 2,974,144 (1961 to Riker)...
...AVAILABLE TO THE PHARMACEUTICAL MANUFACTURER IN FORM OF...PURE CRYSTALLINE ALKALOIDS...RESCINNAMINE...
...DIFFERS STRUCTURALLY FROM RESERPINE IN THAT IT IS TRIMETHOXYCINNAMIC ACID ESTER RATHER THAN TRIMETHOXYBENZOIC ACID ESTER OF METHYL RESERPATE. ... PHARMACOLOGIC ACTIONS OF RESCINNAMINE ARE INDISTINGUISHABLE FROM THOSE OF RESERPINE.